PhRMA DEREGULATION OF EDUCATIONAL MATERIAL AND JOURNAL REPRINTS WOULD RELY ON DEFINITION OF PEER-REVIEWED JOURNALS TO MAINTAIN LEVEL OF SCIENTIFIC DISCOURSE
Executive Summary
The distribution of journal reprints on off-label uses to the medical community would be restricted to articles from about two dozen selected journals, according to a legislative proposal approved by the PhRMA Key Issue Team on FDA reform on June 14.